- Home
- TBPH vs CGNT Comparison
TBPH vs CGNT Comparison
Compare TBPH & CGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBPH
- CGNT
- Stock Information
- Founded
- TBPH 2013
- CGNT 2020
- Country
- TBPH United States
- CGNT Israel
- Employees
- TBPH N/A
- CGNT N/A
- Industry
- TBPH Biotechnology: Pharmaceutical Preparations
- CGNT Computer Software: Prepackaged Software
- Sector
- TBPH Health Care
- CGNT Technology
- Exchange
- TBPH Nasdaq
- CGNT Nasdaq
- Market Cap
- TBPH 418.7M
- CGNT 465.2M
- IPO Year
- TBPH N/A
- CGNT N/A
- Fundamental
- Price
- TBPH $9.69
- CGNT $7.87
- Analyst Decision
- TBPH Buy
- CGNT Hold
- Analyst Count
- TBPH 4
- CGNT 3
- Target Price
- TBPH $13.75
- CGNT $8.25
- AVG Volume (30 Days)
- TBPH 191.3K
- CGNT 231.4K
- Earning Date
- TBPH 11-12-2024
- CGNT 12-11-2024
- Dividend Yield
- TBPH N/A
- CGNT N/A
- EPS Growth
- TBPH N/A
- CGNT N/A
- EPS
- TBPH N/A
- CGNT N/A
- Revenue
- TBPH $63,192,000.00
- CGNT $330,212,000.00
- Revenue This Year
- TBPH $6.93
- CGNT $12.89
- Revenue Next Year
- TBPH $45.31
- CGNT $6.94
- P/E Ratio
- TBPH N/A
- CGNT N/A
- Revenue Growth
- TBPH 15.93
- CGNT 12.00
- 52 Week Low
- TBPH $7.44
- CGNT $4.34
- 52 Week High
- TBPH $11.71
- CGNT $8.70
- Technical
- Relative Strength Index (RSI)
- TBPH 70.66
- CGNT 63.70
- Support Level
- TBPH $9.38
- CGNT $6.80
- Resistance Level
- TBPH $10.10
- CGNT $7.74
- Average True Range (ATR)
- TBPH 0.32
- CGNT 0.28
- MACD
- TBPH 0.11
- CGNT 0.05
- Stochastic Oscillator
- TBPH 83.26
- CGNT 81.62
About TBPH Theravance Biopharma Inc.
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
About CGNT Cognyte Software Ltd.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.